HAART and response to therapy improve quality of life (QOL) of African patients with advanced HIV-associated Kaposi’s sarcoma (HIV-KS): a prospective analysis of QOL in the KAART trial

Схожі ресурси

• The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and chemotherapy in treatment-naïve patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa
  за авторством: Aboobaker J, та інші
  Опубліковано: (2010-10-01)
• Health-Related Quality of Life in Patients Treated With Antiretroviral Therapy Only Versus Chemotherapy and Antiretroviral Therapy for HIV-Associated Kaposi Sarcoma: A Randomized Control Trial
  за авторством: Fahmida Shaik, та інші
  Опубліковано: (2018-10-01)
• Early Changes in Health-Related Quality of Life as a Biomarker of Survival in African Patients with HIV-Associated Kaposi Sarcoma
  за авторством: Fahmida Shaik, та інші
  Опубліковано: (2024-10-01)
• Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770
  за авторством: Skadden D, та інші
  Опубліковано: (2009-06-01)
• Increasing incidence of Kaposi's sarcoma in black South Africans In Kwazulu-Natal, South Africa (1983 to 2006)
  за авторством: Shaik F, та інші
  Опубліковано: (2009-06-01)